Title |
Randomized Controlled Trial of Emergency Transjugular Intrahepatic Portosystemic Shunt Versus Emergency Portacaval Shunt Treatment of Acute Bleeding Esophageal Varices in Cirrhosis
|
---|---|
Published in |
Journal of Gastrointestinal Surgery, September 2012
|
DOI | 10.1007/s11605-012-2003-6 |
Pubmed ID | |
Authors |
Marshall J. Orloff, Florin Vaida, Kevin S. Haynes, Robert J. Hye, Jon I. Isenberg, Horacio Jinich-Brook |
Abstract |
Emergency treatment of bleeding esophageal varices (BEV) in cirrhosis is of paramount importance because of the resultant high mortality rate. Emergency therapy today consists mainly of endoscopic and pharmacologic measures, with use of transjugular intrahepatic portosystemic shunt (TIPS) when bleeding is not controlled. Surgical portosystemic shunt has been relegated to last resort salvage when all other measures fail. Regrettably, no randomized controlled trials have been reported in which TIPS and surgical portosystemic shunt were compared in unselected patients with acute BEV, with long-term follow-up. This is a report of a long-term prospective randomized controlled trial (RCT) that compared TIPS with emergency portacaval shunt (EPCS) in patients with cirrhosis and acute BEV. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 2% |
United States | 1 | 2% |
Unknown | 56 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 16% |
Student > Master | 9 | 16% |
Student > Ph. D. Student | 5 | 9% |
Other | 4 | 7% |
Librarian | 3 | 5% |
Other | 13 | 22% |
Unknown | 15 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 36 | 62% |
Nursing and Health Professions | 2 | 3% |
Philosophy | 1 | 2% |
Immunology and Microbiology | 1 | 2% |
Environmental Science | 1 | 2% |
Other | 2 | 3% |
Unknown | 15 | 26% |